Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Psychiatry Research
|
March 1, 1992
Disorders of smooth pursuit eye movement and auditory N100 in schizophrenic patients
W K Strik, T Dierks, J Böning, et al.
Archives of General Psychiatry
|
June 1, 1991
5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls
K P Lesch, A Hoh, J Disselkamp-Tietze, et al.
Pharmacopsychiatry
|
January 1, 1997
Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine
R W Dittmann, M Linden, M Osterheider, et al.
Archives of General Psychiatry
|
December 15, 2000
Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization
M Driessen, J Herrmann, K Stahl, et al.
Biological Psychiatry
|
October 1, 1990
5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls
K P Lesch, S Mayer, J Disselkamp-Tietze, et al.
Psychopharmacology
|
January 1, 1992
5-HT1A receptor-effector system responsivity in panic disorder
K P Lesch, M Wiesmann, A Hoh, et al.
Anxiety
|
January 1, 1996
Cardio-respiratory and other symptom clusters in panic disorder
B Bandelow, M Amering, O Benkert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 1, 1993
A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group
S A Montgomery, A McIntyre, M Osterheider, et al.
Der Nervenarzt
|
September 1, 1994
[Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry]
M Linden, D Baier, H Beitinger, et al.
Pharmacopsychiatry
|
January 1, 1997
Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP)
M Linden, D Baier, H Beitinger, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Psychiatry Research
|
March 1, 1992
Disorders of smooth pursuit eye movement and auditory N100 in schizophrenic patients
W K Strik, T Dierks, J Böning, et al.
Archives of General Psychiatry
|
June 1, 1991
5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls
K P Lesch, A Hoh, J Disselkamp-Tietze, et al.
Pharmacopsychiatry
|
January 1, 1997
Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine
R W Dittmann, M Linden, M Osterheider, et al.
Archives of General Psychiatry
|
December 15, 2000
Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization
M Driessen, J Herrmann, K Stahl, et al.
Biological Psychiatry
|
October 1, 1990
5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls
K P Lesch, S Mayer, J Disselkamp-Tietze, et al.
Psychopharmacology
|
January 1, 1992
5-HT1A receptor-effector system responsivity in panic disorder
K P Lesch, M Wiesmann, A Hoh, et al.
Anxiety
|
January 1, 1996
Cardio-respiratory and other symptom clusters in panic disorder
B Bandelow, M Amering, O Benkert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 1, 1993
A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group
S A Montgomery, A McIntyre, M Osterheider, et al.
Der Nervenarzt
|
September 1, 1994
[Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry]
M Linden, D Baier, H Beitinger, et al.
Pharmacopsychiatry
|
January 1, 1997
Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP)
M Linden, D Baier, H Beitinger, et al.
Page
of 3